Every week, I hear from people who have been everywhere. Specialists. GPs. Neurologists. Rheumatologists. Gastroenterologists. They’ve tried medications, supplements, elimination protocols designed around generic lists of “common triggers” — and they still feel terrible. Exhausted. In pain. Frustrated.

What most of them have never had is a real food sensitivity test — one that looks at their immune system’s response to their specific foods, with objective, quantified data. Not a guess. Not a generic protocol. A map of exactly which foods are quietly fueling their inflammation every single day.

That test exists. It’s called the Mediator Release Test (MRT®), and in my 20+ years as a registered dietitian, it is the single most powerful clinical tool I have encountered for unraveling chronic, multi-system inflammatory conditions.

I know this because I used it on myself — and published the results. I know it because my clients with debilitating migraines, stubborn PCOS, nerve pain so severe it triggered medical debt, and MCAS flares that derailed their lives have gotten their lives back through this process. And I know it because the clinical evidence — while not yet the product of fifty randomized controlled trials — is compelling, consistent, and growing.

Let me walk you through everything.

What Is the MRT Food Sensitivity Test — and Why Is It Different?

The Mediator Release Test (MRT®) is a patented blood test developed by Oxford Biomedical Technologies, Inc. It tests 176 foods and food chemicals and measures your white blood cells’ actual inflammatory response to each one. It is not an allergy test. It does not measure IgE. It is not an IgG panel. It measures something far more clinically meaningful.

When you eat a food your immune system reacts to — even if you don’t feel it acutely — your white blood cells release a cascade of inflammatory chemicals called mediators: cytokines, histamine, leukotrienes, prostaglandins, and more. These chemicals circulate throughout the body and can trigger symptoms almost anywhere — your joints, your skin, your gut, your sinuses, your brain, your hormonal system.

MRT measures the volumetric change in white blood cells after they’re exposed to each food antigen in the lab. The greater the cell shrinkage, the more mediators were released, and the more inflammatory that food is for you, specifically. Every food gets a Leukocyte Reactivity Index (LRI) score — not a binary yes/no, but a quantified degree of reactivity. This is what makes MRT unique.

Those accuracy numbers — 94.5% sensitivity, 91.8% specificity — are the highest validated accuracy of any commercially available food sensitivity blood test. That’s not a marketing claim; that’s peer-reviewed validation data from Oxford Biomedical Technologies. For context, many popular IgG food sensitivity panels have accuracy data that doesn’t come close.

MRT vs. Other Food Sensitivity Tests: Why the Difference Matters

The food sensitivity test market is crowded and confusing. Most of the popular at-home or clinic-based panels measure IgG antibodies — and while IgG has some clinical relevance, measuring it in isolation is a significant oversimplification of how food sensitivity actually works in the body.

The crucial distinction: food sensitivity reactions are non-IgE-mediated. They involve Type III and Type IV immune pathways, they can be delayed by 4–72 hours after eating, they are dose-dependent, and they vary enormously between individuals. A food that is inflammatory for one person may be among the safest foods for another — even two people with identical diagnoses. This is precisely why generic elimination protocols so often fail.

The Conditions MRT Testing Has Helped My Clients Overcome

When I describe to people what food-driven inflammation can do to the body, they’re often skeptical at first. We’ve been trained to think of food as calories, nutrients, macros — not as immune system inputs that can either quiet or ignite systemic inflammation. But the immune response doesn’t stay in the gut. Mediators circulate. They affect every organ and tissue they reach.

Here are the conditions where I’ve seen MRT + LEAP produce life-changing results — often after years of conventional treatments had failed.

A Note on Chronic Nerve Pain and Medical Debt

This one deserves its own moment. I have worked with clients who were in medical debt — real, life-disrupting financial hardship — from years of neurology appointments, pain management procedures, imaging, specialist referrals, and medications for nerve pain and migraines that never resolved. When a food sensitivity panel in the low-to-mid hundreds of dollars identifies the dietary triggers driving that pain, and the LEAP protocol resolves symptoms within weeks — the cost-effectiveness is staggering. The system failed these people not because the answers didn’t exist, but because no one asked the right question: what is your immune system reacting to in your diet?

Food Sensitivity, Inflammation, and Weight Gain: The Connection Nobody Talks About

If you’ve ever dieted faithfully, exercised consistently, done “everything right,” and still couldn’t lose weight — food-driven inflammation may be why. I’ve written in depth about this at The Healthy RD: how inflammation causes weight gain through bloating, cortisol, and metabolic disruption, and the mechanism is now well-supported in the research literature.

Here’s what happens at a cellular level when you regularly eat foods your immune system reacts to:

My clients — and I myself — have experienced what I can only describe as effortless weight loss after completing the MRT + LEAP protocol. Not because we were eating less, but because we removed the inflammatory load that had been working against our metabolism the entire time. When the immune system quiets, the body can do what it’s designed to do.

Histamine Intolerance & MCAS: Why MRT Goes Deeper Than a Low-Histamine List

If you suspect histamine intolerance or have been told you might have Mast Cell Activation Syndrome (MCAS), you’ve likely found lists of “high-histamine foods to avoid.” These lists can help — but they’re blunt instruments. And for many people, they’re incomplete because the problem isn’t only high-histamine foods. It’s any food that triggers your immune cells to release histamine and other inflammatory mediators.

MRT doesn’t just identify high-histamine foods. It identifies your specific immune triggers across all mediator pathways simultaneously. A food that’s theoretically low in histamine may still provoke significant mast cell and white blood cell mediator release in your immune system — and MRT will catch it. A food on the “avoid” list may score as one of your lowest reactors, meaning it’s actually safe for you.

This is the difference between a generic protocol and a personalized one. For MCAS and histamine-intolerant clients, who often feel like they’re reacting to everything and have narrowed their diet to almost nothing out of fear, MRT provides something invaluable: clarity. A defined set of safe foods. A foundation to rebuild from. A path out of the maze.

The LEAP Protocol: What Happens After Your Test Results

Getting your MRT results is only the first step. The real clinical power comes from what happens next: the LEAP (Lifestyle Eating and Performance) protocol, designed and implemented by a Certified LEAP Therapist (CLT).

LEAP is a structured, phased elimination and reintroduction plan built from your results. Rather than focusing on avoidance (a deprivation-first mindset that tanks compliance), LEAP focuses on what you can eat: your lowest-reactive foods. These become your dietary foundation — a set of approximately 50 foods that form the basis of Phase 1.

What surprises most clients is how not restrictive Phase 1 feels. Your lowest-reactive foods are typically foods you already know and love: proteins you eat regularly, familiar vegetables, grains, fruits, fats. You are not being asked to survive on six foods. You are eating a normal, varied, nourishing diet — just one that has been strategically cleared of every food your immune system is fighting.

Oxford Biomedical Technologies has documented compliance improvement from approximately 40% (with avoidance-based protocols) to over 90% with LEAP — with proportional improvements in outcomes. People actually do this program because it’s built on abundance, not deprivation.

The Clinical Evidence: Honest, Nuanced, and Compelling

I want to address something directly. MRT + LEAP does not have fifty randomized controlled trials behind it. The scale of funding that would be required for that kind of research — and the commercial disincentive for pharmaceutical companies to fund dietary intervention research — means the evidence base, while growing, reflects clinical practice more than it reflects industry-sponsored trials.

Does that make the evidence weak? No. It makes it honest.

What we have is a consistent body of peer-reviewed clinical literature, case series, and practitioner reports — all pointing in the same direction. Here are the key published findings:

The pattern across this literature is remarkably consistent: when individually reactive foods are identified through MRT and removed through LEAP, significant — often dramatic — symptom resolution follows. This is not a coincidence. It reflects a coherent, well-characterized immunological mechanism.

My Own Published Clinical Case: What 96% Symptom Resolution Looks Like

I am a registered dietitian with over 20 years of clinical experience. I eat well. I supplement thoughtfully. I exercise. I sleep. And yet for years, I carried a significant burden of chronic inflammatory symptoms that I could not fully resolve — vestibular migraines that made flying terrifying, post-nasal drip I assumed was seasonal, skin itching that antihistamines barely touched, joint stiffness, insomnia, and hormonal hot flashes I attributed to perimenopause.

I did the MRT test. My highest reactors were sunflower seeds (LRI 3.2), soybean (2.9), halibut (2.7), rooibos tea (2.5) — foods I was eating multiple times per week, including in my “healthy” meal prep. Within 10 days of Phase 1 LEAP, my post-nasal drip was gone. My sinuses — which I had assumed were just chronically inflamed — cleared. The migraines stopped.

The moment that sealed it for me was my first flight after the protocol. For years, flying meant dizziness spiraling out of control, nausea I couldn’t escape, post-flight vomiting. I had nearly accepted that this was just my life. On that first flight after MRT + LEAP, I waited for the misery. It never came. I sat back, looked out the window, and felt completely normal for the first time in years.

Food was the missing piece — not a new medication, not more willpower. Data about my own immune system.

You can read my full published clinical case study, which documents the methodology, MRT results, LEAP phases, and outcome data in detail, at The Healthy RD — How MRT Testing Transformed My Health →

Inflammation Is Not Just Uncomfortable — It’s Deadly: Cancer and Heart Disease Statistics

When we talk about food-driven inflammation, it can be tempting to frame it as a quality-of-life issue — migraines, bloating, itchy skin. But the stakes are far higher than that. Chronic low-grade inflammation is now recognized by researchers as one of the most significant underlying drivers of the two leading causes of death in the United States: heart disease and cancer. Understanding this connection transforms food sensitivity testing from a comfort intervention into a potential life-extension strategy.

The Cancer–Inflammation Connection: What the Research Shows

The relationship between chronic inflammation and cancer is one of the most robustly documented areas in modern oncology. Epidemiological data published across multiple peer-reviewed journals converge on a striking figure: at least 15–20% of all cancers worldwide are directly associated with chronic inflammatory processes — triggered by infections, exposure to environmental irritants, autoimmune activity, or diet-driven immune dysregulation.

A 2024 editorial published in Frontiers in Medicine (Orlando & Mainous, PMC11249529) confirmed that inflammation is directly associated with the morbidity and mortality of cardiovascular disease, cancer, chronic kidney disease, diabetes, non-alcoholic fatty liver disease, autoimmune diseases, and neurodegenerative disorders. The same research found that elevated inflammation alone confers roughly a 50% increased risk in all-cause mortality in adults aged 40 and older.

A comprehensive 2024 review in Frontiers in Pharmacology (PMC11117078) confirmed the mechanism: chronic inflammation creates a tissue microenvironment that promotes DNA damage through reactive oxygen and nitrogen species, sustains tumor cell survival and proliferation, encourages angiogenesis, and suppresses the immune system’s natural anti-tumor responses. In short, inflammation doesn’t just passively coexist with cancer — it actively builds the environment cancer needs to thrive.

The Heart Disease–Inflammation Connection: A 50% Increased Mortality Risk

Heart disease remains the leading cause of death in the United States, responsible for 1 in every 3 deaths — 919,032 Americans died from cardiovascular disease in 2023 alone (CDC, 2024). What the mainstream conversation often underemphasizes is how deeply inflammation is woven into that death toll.

Inflammation is not merely a downstream consequence of atherosclerosis — it is a primary driver of it. A 2023 meta-analysis published in Frontiers in Cardiovascular Medicine (PMC10360053) pooled data across studies and confirmed that four inflammatory biomarkers — fibrinogen, IL-6, CRP, and galectin-3 — are each independently and significantly associated with cardiovascular disease development. Elevated CRP alone conferred a 25% increased odds of developing cardiovascular disease (OR: 1.25; 95% CI: 1.15–1.35).

CRP is mechanistically implicated in endothelial dysfunction, oxidative stress, and arterial plaque destabilization — the same processes that lead to heart attack and stroke. A 2025 review in Current Atherosclerosis Reports (PMID 40014057) confirmed that anti-inflammatory therapies specifically targeting IL-1β and CRP pathways reduce cardiovascular events — a direct validation that inflammation is causal, not merely correlational, in heart disease.

And critically: the NHANES 2015–2020 population data (PMC10808594) found that 34.6% of US adults already have elevated systemic inflammation — most of them undiagnosed and unscreened. Among adults with undiagnosed cardiometabolic disease, that figure climbs to 29.1%, and among those with diagnosed disease, to 41.8%. Inflammation is not a rare finding. It is a population-level crisis hiding in plain sight.

Why Diet-Driven Inflammation Matters in This Context

Here is where the MRT food sensitivity test becomes more than a symptom-management tool. If chronic inflammation drives cancer and heart disease at the scale the research documents — and if a significant portion of that inflammation is being fueled daily by individually reactive foods that standard testing doesn’t detect — then identifying and removing those foods is not a minor lifestyle tweak. It is a meaningful reduction in long-term disease risk.

The foods that triggered my immune system most severely — sunflower seeds, soybean, rooibos tea — were foods I was consuming multiple times per week under the assumption that they were health-promoting. My white blood cells were mounting an inflammatory response to them every single day. That sustained mediator release — cytokines, prostaglandins, leukotrienes circulating through my body — is precisely the kind of chronic low-grade inflammation that the research links to cardiovascular damage, immune dysregulation, and increased cancer risk over time.

This doesn’t mean that food sensitivity testing prevents cancer or heart disease — no responsible clinician would claim that. What the evidence supports is that chronic systemic inflammation is a measurable, modifiable risk factor for both conditions, and that diet-driven inflammation is a meaningful and frequently overlooked contributor to that burden. Understanding the full scope of how inflammation affects the body is the first step toward addressing it at its root.

The Hidden Cost of Not Testing

Let’s talk about money — because this matters. When someone with chronic migraines spends years cycling through preventive medications, abortive medications, neurologist appointments, imaging studies, and procedures — the cost adds up to thousands, sometimes tens of thousands of dollars. When a fibromyalgia patient or someone with severe nerve pain builds medical debt across pain management, physical therapy, specialist referrals, and prescription trials — and nothing resolves — the human and financial cost is devastating.

An MRT food sensitivity panel and a package of LEAP therapy sessions is a fraction of that cost. And unlike medications that manage symptoms while the underlying inflammatory trigger remains active, the LEAP protocol addresses the root cause. When the reactive foods are gone, the inflammation quiets — and in many cases, it stays quiet.

This is not a criticism of conventional medicine. It is an observation that diet-driven inflammation is systematically undertested in conventional workups for chronic inflammatory conditions — and that closing that gap can make an enormous difference for patients who have been suffering for years.